Thus, EZH2 suppression following T/P-induced senescence triggers a phenotypic switch in the SASP program in the PDAC TME from a pro-angiogenic SASP to a pro-inflammatory SASP that may contribute to enhanced cytotoxic lymphocyte anti-tumor immunity. Here, EZH2 is linked to neoplasm.